Matrix Metalloproteinases as Novel Biomarker S and Potential Therapeutic Targets in Human Cancer

Journal of Clinical Oncology- United States

doi 10.1200/jco.2009.23.5556

Full Text

Abstract

Available in

Categories

Cancer Research

Date

November 1, 2009

Authors

Marsha A. Moses

Publisher

American Society of Clinical Oncology (ASCO)

Related search

Matrix Metalloproteinases as Potential Targets in the Venous Dilation Associated With Varicose Veins

Current Drug Targets

Molecular Medicine

Clinical Biochemistry

English

C-Met as a Potential Therapeutic Target and Biomarker in Cancer

Therapeutic Advances in Medical Oncology

English

MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer

Journal of Oncology

English

Acute Actions and Novel Targets of Matrix Metalloproteinases in the Heart and Vasculature

British Journal of Pharmacology

English

Editorial: Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies

Frontiers in Pharmacology

English

Matrix Metalloproteinases in Cancer

Essays in Biochemistry

Molecular Biology

English

Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian Cancer

Frontiers in Oncology

Cancer Research

English

GPCRs as Potential Therapeutic Targets in Preeclampsia

Drug Discovery Today: Disease Models

Molecular Medicine

English

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma

International Journal of Hematology-Oncology and Stem Cell Research

Transplantation

English